New evidence points to a possible role for GLP‑1 drugs in substance use care Researchers and clinicians are increasingly examining whether medications developed for diabetes and weight loss could also reduce harmful substance use. Multiple observational studi…
Researchers and clinicians are increasingly examining whether medications developed for diabetes and weight loss could also reduce harmful substance use. Multiple observational studies and early expe… [+2128 chars]
